Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, United States.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States.
Metabolism. 2018 Jul;84:85-93. doi: 10.1016/j.metabol.2018.01.021. Epub 2018 Feb 1.
Type 2 diabetes (T2D) and sleep disturbance (e.g., insomnia, sleep-disordered breathing) are prevalent conditions among older adults that are associated with cognitive decline and dementia, including Alzheimer's disease (AD). Importantly, disturbed sleep is associated with alterations in insulin sensitivity and glucose metabolism, and may increase the risk of T2D, and T2D-related complications (e.g., pain, nocturia) can negatively affect sleep. Despite these associations, little is known about how interactions between T2D and sleep disturbance might alter cognitive trajectories or the pathological changes that underlie dementia. Here, we review links among T2D, sleep disturbance, cognitive decline and dementia-including preclinical and clinical AD-and identify gaps in the literature, that if addressed, could have significant implications for the prevention of poor cognitive outcomes.
2 型糖尿病(T2D)和睡眠障碍(如失眠、睡眠呼吸障碍)在老年人中很常见,它们与认知能力下降和痴呆症有关,包括阿尔茨海默病(AD)。重要的是,睡眠障碍与胰岛素敏感性和葡萄糖代谢的改变有关,并可能增加 T2D 的风险,而 T2D 相关的并发症(如疼痛、夜尿症)会对睡眠产生负面影响。尽管存在这些关联,但人们对 T2D 和睡眠障碍之间的相互作用如何改变认知轨迹或痴呆症的潜在病理变化知之甚少。在这里,我们回顾了 T2D、睡眠障碍、认知能力下降和痴呆症(包括临床前和临床 AD)之间的联系,并确定了文献中的空白,如果加以解决,可能对预防认知能力下降产生重大影响。